相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers
Arnoud Boot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Topoisomerase II Poisons: Converting Essential Enzymes into Molecular Scissors
Kendra R. Vann et al.
BIOCHEMISTRY (2021)
Structural basis for allosteric regulation of Human Topoisomerase IIα
Arnaud Vanden Broeck et al.
NATURE COMMUNICATIONS (2021)
Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer Related Targets
Ziga Skok et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, Synthesis, Dynamic Docking, Biochemical Characterization, and in Vivo Pharmacokinetics Studies of Novel Topoisomerase II Poisons with Promising Antiproliferative Activity
Jose M. Arencibia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of new ATP-competitive inhibitors of human DNA topoisomerase IIα through screening of bacterial topoisomerase inhibitors
Ziga Skok et al.
BIOORGANIC CHEMISTRY (2020)
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β
Jose Antonio Ortega et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors
Davide Benedetto Tiz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-b]pyridinol Derivatives as Potent Topoisomerase IIα-Targeted Chemotherapeutic Agents for Breast Cancer
Tara Man Kadayat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity
Martina Durcik et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches
Wei Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain
Claire Bedez et al.
SCIENTIFIC REPORTS (2018)
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis
Tino Heinnburg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Topoisomerase II and leukemia
MaryJean Pendleton et al.
BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT (2014)
Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase IIα As Novel Anticancer Agents
B. Pogorelcnik et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
Christian Bailly
CHEMICAL REVIEWS (2012)
Derivatives of Heteroarylsulfonamides, Their Preparation, and Their Application in Human Therapy Patent Highlight
Benjamin Blass
ACS MEDICINAL CHEMISTRY LETTERS (2012)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
DNA topoisomerase II and its growing repertoire of biological functions
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase
H Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors
LH Jensen et al.
CANCER RESEARCH (2005)
Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187
S Classen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
GHKL, an emergent ATPase/kinase superfamily
R Dutta et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
分享论文
